256 related articles for article (PubMed ID: 21439158)
1. Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor.
Ciprandi G; Tosca MA; Signori A; Cirillo I
Allergy Asthma Proc; 2011; 32(2):4-8. PubMed ID: 21439158
[TBL] [Abstract][Full Text] [Related]
2. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis.
Ciprandi G; Tosca MA; Castellazzi AM; Cairello F; Salpietro C; Arrigo T; Miraglia Del Giudice M
Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):17-20. PubMed ID: 22032781
[TBL] [Abstract][Full Text] [Related]
3. Forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor for bronchial hyperreactivity in children with allergic rhinitis, asthma, or both.
Ciprandi G; Tosca MA; Capasso M
Allergy Asthma Proc; 2011; 32(5):e22-8. PubMed ID: 22195682
[TBL] [Abstract][Full Text] [Related]
4. Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis.
Ciprandi G; Signori A; Cirillo I
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):460-6. PubMed ID: 21624744
[TBL] [Abstract][Full Text] [Related]
5. Lower airways may also be affected in asymptomatic patients with recent onset of allergic rhinitis.
Ciprandi G; Cirillo I; Klersy C
Laryngoscope; 2010 Jul; 120(7):1288-91. PubMed ID: 20578230
[TBL] [Abstract][Full Text] [Related]
6. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.
Marseglia GL; Cirillo I; Vizzaccaro A; Klersy C; Tosca MA; La Rosa M; Marseglia A; Licari A; Leone M; Ciprandi G
Allergy Asthma Proc; 2007; 28(1):74-8. PubMed ID: 17390762
[TBL] [Abstract][Full Text] [Related]
7. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis.
Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
Int Arch Allergy Immunol; 2004 Jan; 133(1):14-8. PubMed ID: 14646374
[TBL] [Abstract][Full Text] [Related]
8. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
[TBL] [Abstract][Full Text] [Related]
9. Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine.
Ciprandi G; Ricciardolo FL; Schiavetti I; Cirillo I
Am J Rhinol Allergy; 2014; 28(6):214-8. PubMed ID: 25514477
[TBL] [Abstract][Full Text] [Related]
10. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis.
Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
Respir Med; 2004 Sep; 98(9):826-31. PubMed ID: 15338793
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function parameters in patients with allergic rhinitis.
Bavbek S; Saryal S; Karabiyikoglu G; Misirligil Z
J Investig Allergol Clin Immunol; 2003; 13(4):252-8. PubMed ID: 14989114
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilation test in patients with allergic rhinitis.
Ciprandi G; Signori A; Tosca MA; Cirillo I
Allergy; 2011 May; 66(5):694-8. PubMed ID: 21261662
[TBL] [Abstract][Full Text] [Related]
13. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide.
Aronsson D; Tufvesson E; Bjermer L
Clin Exp Allergy; 2005 Nov; 35(11):1457-61. PubMed ID: 16297142
[TBL] [Abstract][Full Text] [Related]
14. Early bronchial involvement in children with allergic rhinitis.
Ciprandi G; Capasso M; Tosca MA
Am J Rhinol Allergy; 2011; 25(1):e30-3. PubMed ID: 21711971
[TBL] [Abstract][Full Text] [Related]
15. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis.
Mete N; Sin A; Gulbahar O; Erdinc M; Sebik F; Kokuludag A
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):193-9. PubMed ID: 15328682
[TBL] [Abstract][Full Text] [Related]
16. Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis.
Cirillo I; Vizzaccaro A; Tosca MA; Negrini S; Negrini AC; Marseglia G; Ciprandi G
Monaldi Arch Chest Dis; 2005 Jun; 63(2):79-83. PubMed ID: 16128221
[TBL] [Abstract][Full Text] [Related]
17. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
[TBL] [Abstract][Full Text] [Related]
18. Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.
Cirillo I; Medusei G; Signori A; Ciprandi G
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):123-9. PubMed ID: 24067337
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bronchial hyperreactivity with mannitol dry powder challenge test in a paediatric population with intermittent allergic asthma or allergic rhinitis.
Decimo F; Capristo C; Amelio R; Maiello N; Capristo AF; Miraglia Del Giudice M
Int J Immunopathol Pharmacol; 2011; 24(4):1069-74. PubMed ID: 22230412
[TBL] [Abstract][Full Text] [Related]
20. Impact of allergic rhinitis on asthma in children: effects on bronchial hyperreactivity.
Ciprandi G; Tosca MA; Cirillo I; Capasso M
Allergy; 2010 Sep; 65(9):1199-201. PubMed ID: 20132159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
